Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Operating Expenses (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Operating Expenses for 16 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 3.19% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, up 6.89% year-over-year, with the annual reading at $6.1 million for FY2025, 6.89% up from the prior year.
  • Operating Expenses for Q4 2025 was $1.9 million at Creative Medical Technology Holdings, up from $1.3 million in the prior quarter.
  • The five-year high for Operating Expenses was $6.3 million in Q4 2022, with the low at $303944.0 in Q1 2021.
  • Average Operating Expenses over 5 years is $1.5 million, with a median of $1.3 million recorded in 2025.
  • The sharpest move saw Operating Expenses soared 351.35% in 2021, then crashed 71.81% in 2023.
  • Over 5 years, Operating Expenses stood at $1.5 million in 2021, then soared by 319.1% to $6.3 million in 2022, then plummeted by 71.81% to $1.8 million in 2023, then rose by 6.42% to $1.9 million in 2024, then increased by 3.19% to $1.9 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $1.9 million, $1.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.